Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (PPWD1) is a multifunctional nuclear enzyme that possesses both a peptidyl-prolyl cis-trans isomerase (PPIase) domain and WD repeat motifs. PPWD1 catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides—a key step in protein folding and regulation[5][6][7]. It acts within the spliceosome complex and is believed to play roles in pre-mRNA splicing and possibly other cellular processes. While annotated as a protein-coding gene with enzymatic activity, there are currently no direct drugs or mechanisms targeting PPWD1, but it may be indirectly implicated in disease, for example, as a partner in cancer-related gene fusions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (PPWD1).